Literature DB >> 9215268

Why retest young adults with childhood-onset growth hormone deficiency?

H de Boer, E A van der Veen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9215268     DOI： 10.1210/jcem.82.7.4101

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Metabolic effects of discontinuing growth hormone treatment.

Authors:  F J Cowan; W D Evans; J W Gregory
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

2.  Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Authors:  G Aimaretti; R Attanasio; S Cannavò; M C Nicoletti; R Castello; C Di Somma; P Garofalo; L Iughetti; S Loche; M Maghnie; L Mazzanti; G Saggese; M Salerno; G Tonini; V Toscano; S Zucchini; M Cappa
Journal:  J Endocrinol Invest       Date:  2014-11-02       Impact factor: 4.256

Review 3.  Growth hormone deficiency in the transition period: body composition and gonad function.

Authors:  G Balercia; L Giovannini; F Paggi; M Spaziani; N Tahani; M Boscaro; A Lenzi; A Radicioni
Journal:  J Endocrinol Invest       Date:  2011-06-21       Impact factor: 4.256

Review 4.  Growth hormone replacement therapy: transition from adolescence to adulthood.

Authors:  Mitchell E Geffner
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-01

5.  Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.

Authors:  Merih Berberoğlu; Zeynep Sıklar; Feyza Darendeliler; Sükran Poyrazoğlu; Sükran Darcan; Pınar Işgüven; Aysun Bideci; Gönül Ocal; Rüveyde Bundak; Bilgin Yüksel; Ilknur Arslanoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-08-05

6.  Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).

Authors:  Daojun Mo; Dana Sue Hardin; Eva Marie Erfurth; Shlomo Melmed
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

7.  An audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland.

Authors:  M Ahmid; V Fisher; A J Graveling; S McGeoch; E McNeil; J Roach; J S Bevan; L Bath; M Donaldson; G Leese; A Mason; C G Perry; N N Zammitt; S F Ahmed; M G Shaikh
Journal:  Int J Pediatr Endocrinol       Date:  2016-03-16

Review 8.  Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective.

Authors:  M Ahmid; S F Ahmed; M G Shaikh
Journal:  Ther Clin Risk Manag       Date:  2018-11-23       Impact factor: 2.423

9.  Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?

Authors:  Laura Penta; Marta Cofini; Laura Lucchetti; Letizia Zenzeri; Alberto Leonardi; Lucia Lanciotti; Daniela Galeazzi; Alberto Verrotti; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-01-23       Impact factor: 3.390

10.  The Challenge of Growth Hormone Deficiency Diagnosis and Treatment during the Transition from Puberty into Adulthood.

Authors:  Elena Inzaghi; Stefano Cianfarani
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.